Corporate governance and securities law compliance

Our attorneys represent CASI Pharmaceuticals, Inc., a biotechnology company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, with respect to corporate governance and securities law compliance including capital markets activities and SEC reporting and filings.